PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly (Q44295528)

1 December 2017

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly (English)

1 reference

1 December 2017

2

1 reference

1 December 2017

9

Gregory J Cooney

1 reference

1 December 2017

11

Edward W Kraegen

1 reference

1 December 2017

Ji-Ming Ye

1

1 reference

1 December 2017

David G Watson

3

1 reference

1 December 2017

Bronwyn Ellis

4

1 reference

1 December 2017

Leonie Wood

5

1 reference

1 December 2017

Per Bo Jensen

6

1 reference

1 December 2017

Rikke Veggerby Sørensen

7

1 reference

1 December 2017

Philip Just Larsen

8

1 reference

1 December 2017

Karsten Wassermann

10

1 reference

1 December 2017

1 March 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

1 December 2017

1 reference

1 December 2017

284

1 reference

1 December 2017

E531-40

1 reference

1 December 2017

3

1 reference

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Surgical removal of visceral fat reverses hepatic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

mRNA Profiling of Rat Islet Tumors Reveals Nkx 6.1 as a β-Cell-specific Homeodomain Transcription Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Unraveling the mechanism of action of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Drug treatment of lipid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor ex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Abundant expression of uncoupling protein-2 in the small intestine: up-regulation by dietary fish oil and fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00299.2002

10.1152/AJPENDO.00299.2002

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference